Biggest News Aggregation in the World
📰 Ioscience News

Page 31 - Ioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ioscience. Real-time updates on events, politics, business and more.

Lexaria Bioscience Corp.: Lexaria's DehydraTECH-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus

KELOWNA, BC / ACCESSWIRE / June 3, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that remdesivir
John Docherty Chris Bunka Lexaria Dehydra Exchange Commission Lexaria Bioscience Corp Company Or Lexaria

Epithelial Cell Culture: Regional Outlook, Current & Upcoming Trends Analysis 2028 with Key Players like PromoCell GmbH, Merck KGaA, Axol Bioscience Ltd.

Epithelial Cell Culture: Regional Outlook, Current & Upcoming Trends Analysis 2028 with Key Players like PromoCell GmbH, Merck KGaA, Axol Bioscience Ltd. iCrowd Newswire A new market study report by The Insight Partners on the Epithelial Cell Culture Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative in...
United States Promocell Gmb Celprogen Inc Axol Bioscience Ltd Merck Kga Research Newswire

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Lexaria Bioscience Corp.: Lexaria's Newest DehydraTECH 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever

Lexaria Bioscience Corp.: Lexarias Newest DehydraTECH 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever Human clinical hypertension study HYPER-H21-1 also progressing KELOWNA, BC / ACCESSWIRE / May 20, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce successful test results of two new "DehydraTECH 2.0" cannabidiol ("CBD") fo...
United States Chris Bunka Exchange Commission Lexaria Bioscience Corp Company Or Lexaria Drug Administration

Lexaria Bioscience Corp.: Lexaria Strengthens Its International Patent Portfolio to 19 Patents Granted

Lexaria Bioscience Corp.: Lexaria Strengthens Its International Patent Portfolio to 19 Patents Granted New patent granted in India bolsters worldwide patent coverage, adding to existing patents in the EU, the U.S., and Australia KELOWNA, BC / ACCESSWIRE / May 12, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces further expansion of its intellectual property portfolio with its first-ever pa...
Chris Bunka Exchange Commission Company Or Lexaria Lexaria Bioscience Corp Drug Administration Lexaria Bioscience

Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field

Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field LUND, Sweden, May 4, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research agreement with BioArctic AB, a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimers disease and Parkinsons disease. Under the agreement...
Malin Carlsson Aptevo Therapeutics Inc Shanghai Henlius Biotech Inc Head Of Research At Bioarctic Nasdaq Stockholm Vice President

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science